A two-year weight reduction program in obese sleep apnea patients

Journal of Clinical Sleep Medicine

Volumn 6, Issue 5, 2010, Pages 479-486

  Nerfeldt, Pia ^a   Nilsson, Bengt Y ^a   Mayor, Liliana ^a   Uddén, Joanna ^a   Friberg, Danielle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Behavioral therapy; Diet; Obesity; Quality of life; Sleep apnea; Sleepiness; Weight reduction

Indexed keywords

INSULIN; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ADULT; AGED; APNEA HYPOPNEA INDEX; AROUSAL; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR THERAPY; BODY MASS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEVICE THERAPY; EPWORTH SLEEPINESS SCALE; FEMALE; GENDER; GROUP THERAPY; HEALTH PROGRAM; HUMAN; INSULIN BLOOD LEVEL; INTERVENTION STUDY; LOW CALORY DIET; MALE; MANDIBULAR RETAINING DEVICE; METABOLIC PARAMETERS; NIGHT; OBESITY; OXYGEN DESATURATION INDEX; OXYGEN SATURATION; PHYSICAL CAPACITY; POSITIVE END EXPIRATORY PRESSURE; PROSPECTIVE STUDY; QUALITY OF LIFE; RESPIRATORY DISTRESS; SLEEP; SLEEP APNEA SYNDROME; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 78149322678     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.27939     Document Type: Article

References (38)

1. Guilleminault C, Van Den Hoed J, Mitler MM. Clinical overview of the sleep apnoea syndromes. In: Guilleminault C, Dement WC, eds. Sleep apnoea syndromes. New York: Alan R. Liss, 1987:1-12.
2. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
3. Jain V. Clinical perspective of obstructive sleep apnea-induced cardiovascular complications. Antioxid Redox Signal 2007;9:701-10.
4. Dyugovskaya L, Polyakov A, Lavie P, Lavie L. Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med 2008;177:544-54.
5. Schuster SR, Tabba M, Sahota P. Relationship between the cardiometabolic syndrome and obstructive sleep apnea. J Cardiometab Syndr 2006;1:204-8.
6. Bassiri A, Guilleminault C. Clinical features and evaluation of obstructive sleep apnea-hypopnea syndrome. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of Sleep Medicine, 3rd ed. Philadelphia: WB Saunders Company, 2000:869-78.
7. Shelton KE, Woodson H, Gay S, Suratt PM. Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis 1993;148:462-6.
8. Shepard JW, Getter WB, Guilleminault C et al. Evaluation of the upper airway in patients with obstructive sleep apnea. Sleep 1991;14:361-71.
9. Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A. Sleep apnea and sleep disruption in obese patients. Arch Intern Med 1994;154:1705-11.
10. Richman RM, Elliott LM, Burns CM, Bearpark HM, Steinbeck KS, Caterson ID. The prevalence of obstructive sleep apnoea in an obese female population. Int J Obes Relat Metab Disord 1994;18:173-7.
11. Noseda A, Kempenaers C, Kerkhofs M, Houben JJ, Linkowski P. Sleep apnea after 1 year domiciliary nasal-continuous positive airway pressure and attempted weight reduction. Potential for weaning from continuous positive airway pressure. Chest 1996;109:138-43.
12. Smith PL, Gold AR, Meyers DA, Haponik EF, Bleecker ER. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985;103:850-5.
13. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015-21.
14. Suratt PM, McTier RF, Findley LJ, Pohl SL, Wilhoit SC. Effect of very-low-calorie diets with weight loss on obstructive sleep apnea. Am J Clin Nutr 1992;56:182S-4S.
15. Schwartz AR, Gold AR, Schubert N, et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 1991;144:494-8.
16. Busetto L, Enzi G, Inelmen EM, et al. Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon. Chest 2005;128:618-23.
17. Flum DR, Salem L, Elrod JA, Dellinger EP, Cheadle A, Chan L. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA 2005;294:1903-8.
18. Gasteyger C, Larsen TM, Vercruysse F, Astrup A. Effect of a dietary-induced weight loss on liver enzymes in obese subjects. Am J Clin Nutr 2008;87:1141-7.
19. Bravata DM, Sanders L, Huang J, et al. Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA 2003;289:1837-50.
20. Nerfeldt P, Nilsson BY, Uddén J, Rössner S, Friberg D. Weight reduction improves nocturnal respiration in obese sleep apnoea patients - a randomized controlled pilot study. Obes Res Clin Pract 2008;2:119-24.
21. Nerfeldt P, Nilsson BY, Mayor L, Uddén J, Rössner S, Friberg D. Weight reduction improves sleep, sleepiness and metabolic status in obese sleep apnoea patients. Obes Res Clin Pract 2008;2:251-62.
22. Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. Prog Behav Modif 1992;28:183-218.
23. McNicholas WT, Bonsignore MR, Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-78.
24. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992;16:397-415.
25. Pekkarinen T, Takala I, Mustajoki P. Two year maintenance of weight loss after a VLCD and behavioural therapy for obesity: correlation to the scores of questionnaires measuring eating behaviour. Int J Obes Relat Metab Disord 1996;20:332-7.
26. Anderson JW, Vichitbandra S, Qian W, Kryscio RJ. Long-term weight maintenance after an intensive weight-loss program. J Am Coll Nutr 1999;18:620-7.
27. Kajaste S, Brander PE, Telakivi T, Partinen M, Mustajoki P. A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med 2004;5:125-31.
28. Marklund M, Franklin KA. Long-term effects of mandibular repositioning appliances on symptoms of sleep apnoea. J Sleep Res 2007;16:414-20.
29. Marklund M, Sahlin C, Stenlund H, Persson M, Franklin KA. Mandibular advancement device in patients with obstructive sleep apnea: long-term effects on apnea and sleep. Chest 2001;120:162-9.
30. Grote L, Hedner J, Grunstein R, Kraiczi H. Therapy with nCPAP: incomplete elimination of sleep related breathing disorder. Eur Respir J 2000;16:921-7.
31. Lindberg E, Berne C, Elmasry A, Hedner J, Janson C. CPAP treatment of a population-based sample - what are the benefits and the treatment compliance? Sleep Med 2006;7:553-60.
32. Mustajoki P, Pekkarinen T. Very low energy diets in the treatment of obesity. Obes Rev 2001;2:61-72.
33. D'Ambrosio C, Bowman T, Mohsenin V. Quality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure - a prospective study. Chest 1999;115:123-9.
34. Moyer CA, Sonnad SS, Garetz SL, Helman JI, Chervin RD. Quality of life in obstructive sleep apnea: a systematic review of the literature. Sleep Med 2001;2:477-91.
35. Larsson U, Karlsson J, Sullivan M. Impact of overweight and obesity on health-related quality of life - a Swedish population study. Int J Obes Relat Metab Disord 2002;26:417-24.
36. Kolotkin RL, Meter K, Williams GR. Quality of life and obesity. Obes Rev 2001;2:219-29.
37. Kaukua J, Pekkarinen T, Sane T, Mustajoki P. Health-related quality of life in obese outpatients losing weight with very-low-energy diet and behaviour modification - a 2-y follow-up study. Int J Obes Relat Metab Disord 2003;27:1233-41.
38. Phillips CL, Yang Q, Williams A et al. The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea. J Sleep Res 2007;16:217-25.